Stimulators of tissue-type plasminogen activator

A novel method, COAMATIC® plasmin inhibitor, for the specific determination of Plasmin Inhibitor activity in plasma

Interaction of reteplase with heparin. A comparison between reteplase and alteplase

Alu-repeat polymorphism in the tissue-type plasminogen activator (t-PA) gene, t-PA levels and risk of familial myocardial infarction (MI)

Update 1996: Blood collection and handling procedures for assessment of plasminogen activators and inhibitors (Leiden Fibrinolysis Workshop)

Intraperitoneal coagulation and fibrinolysis during inflammation: In vivo and in vitro observations

The plasminogen activation system in rheumatoid arthritis

Usefulness and limitations of Actilyse® for standardisation of tissue-type plasminogen activator (t-PA) assays in blood

The use of Stabilyte® plasma may cause changes in pH in the assay of some fibrinolysis analytes and might effect results

Inhibition of urokinase-type and tissue-type plasminogen activator - Mediated plasminogen activation by doxycycline

Analysis of activation markers off coagulation, fibrinolysis and inflammation in unstable angina by probit transformation

Stimulation of tissue-type plasminogen activator expression by retinoic acid in human endothelial cells requires retinoic acid receptor β2 induction

Criteria for a specific plasmin inhibition test (SPIT) in human plasma

Fibrinolytic capacity and risk of myocardial infarction

Interactions between staphylokinase, plasmin(ogen), and fibrin. Staphylokinase discriminates between free plasminogen and plasminogen bound to partially degraded fibrin

Rearrangements of the fibrin network and spatial distribution of fibrinolytic components during plasma clot lysis: Study with confocal microscopy

Familial dysfibrinogenemia and thrombophilia - Report on a study of the SSC subcommittee on fibrinogen

Beneficial effect of a moderately energy-restricted diet on fibrinolytic factors in non-obese men

Comparison of the inhibition of urokinase-type plasminogen activator (u-PA) activity by monoclonal antibodies specific for u-PA as assessed by different assays

Acute release of tissue-type plasminogen activator (t-PA) from the endothelium ; regulatory mechanisms and therapeutic target